21. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. (10th November 2020) Authors: Deshpande, Shayu; Tytarenko, Ruslana G.; Wang, Yan; Boyle, Eileen M.; Ashby, Cody; Schinke, Carolina D.; Thanendrarajan, Sharmilan; Zangari, Maurizio; Zhan, Fenghuang; Davies, Faith E.; Morgan, Gareth J.; van Rhee, Frits; Walker, Brian A. Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Monitoring treatment response and disease progression in myeloma with circulating cell‐free DNA. (10th November 2020) Authors: Deshpande, Shayu; Tytarenko, Ruslana G.; Wang, Yan; Boyle, Eileen M.; Ashby, Cody; Schinke, Carolina D.; Thanendrarajan, Sharmilan; Zangari, Maurizio; Zhan, Fenghuang; Davies, Faith E.; Morgan, Gareth J.; van Rhee, Frits; Walker, Brian A. Journal: European journal of haematology Issue: Volume 106:Number 2(2021) Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?. (March 2016) Authors: Thanendrarajan, Sharmilan; Davies, Faith E; Morgan, Gareth J; Schinke, Carolina; Mathur, Pankaj; Heuck, Christoph J; Zangari, Maurizio; Epstein, Joshua; Yaccoby, Shmuel; Weinhold, Niels; Barlogie, Bart; van Rhee, Frits Journal: Immunotherapy Issue: Volume 8:Number 3(2016:Mar.) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Newly diagnosed and previously treated multicentric Castleman disease respond equally to siltuximab. (31st October 2020) Authors: van Rhee, Frits; Rossi, Jean‐François; Simpson, David; Fosså, Alexander; Dispenzieri, Angela; Kuruvilla, John; Goh, Yeow Tee; Cho, Seok‐Goo; Capra, Marcelo; Liu, Ting; Casper, Corey; Cavet, James; Wong, Raymond S. Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Overall Survival Analysis of the Use of Elotuzumab in ELOQUENT-3 Trial. Issue 9 (20th March 2023) Authors: Al Hadidi, Samer; van Rhee, Frits Journal: Journal of clinical oncology Issue: Volume 41:Issue 9(2023) Page Start: 1788 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Persistent bone marrow minimal residual disease as a "high‐risk" disease feature in multiple myeloma. Issue 9 (29th June 2021) Authors: Mohan, Meera; Szabo, Aniko; Yarlagadda, Naveen; Gundarlapalli, Sravani; Thanendrarajan, Sharmilan; Kendrick, Samantha; Schinke, Carolina; Alapat, Daisy; Sawyer, Jeffrey; Tian, Erming; Tricot, Guido; van Rhee, Frits; Zangari, Maurizio Journal: American journal of hematology Issue: Volume 96:Issue 9(2021) Page Start: E341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease. Issue 7 (16th May 2018) Authors: Pierson, Sheila K.; Stonestrom, Aaron J.; Shilling, Dustin; Ruth, Jason; Nabel, Christopher S.; Singh, Amrit; Ren, Yue; Stone, Katie; Li, Hongzhe; van Rhee, Frits; Fajgenbaum, David C. Journal: American journal of hematology Issue: Volume 93:Issue 7(2018:Jul.) Page Start: 902 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Predictors of response to anti‐IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data. (11th September 2018) Authors: Morra, Deanna E.; Pierson, Sheila K.; Shilling, Dustin; Nemat, Sepideh; Appiani, Carlos; Guilfoyle, Mary; Tendler, Craig; van Rhee, Frits; Fajgenbaum, David C. Journal: British journal of haematology Issue: Volume 184:Number 2(2019) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Siltuximab for multicentric Castleman disease. Issue 5 (October 2014) Authors: Liu, Yi-Chang; Stone, Katie; van Rhee, Frits Journal: Expert review of hematology Issue: Volume 7:Issue 5(2014) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma. Issue 6 (21st March 2022) Authors: Mohan, Meera; Gundarlapalli, Sravani; Szabo, Aniko; Yarlagadda, Naveen; Kakadia, Sunilkumar; Konda, Manojna; Jillella, Anusha; Fnu, Amisha; Ogunsesan, Yetunde; Yarlagadda, Lakshmi; Thalambedu, Nishant; Munawar, Hussain; Graziutti, Monica; Al Hadidi, Samer; Alapat, Daisy; Thanendrarajan, Sharmilan... Journal: American journal of hematology Issue: Volume 97:Issue 6(2022) Page Start: E195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗